Triton Financial Group Inc acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor acquired 13,829 shares of the company’s stock, valued at approximately $1,777,000.
A number of other hedge funds have also added to or reduced their stakes in the stock. Frazier Financial Advisors LLC purchased a new position in shares of Merck KGaA during the second quarter worth approximately $25,000. Rakuten Securities Inc. bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $27,000. Delos Wealth Advisors LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at approximately $33,000. Solstein Capital LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at approximately $33,000. Finally, Burk Holdings LLC bought a new position in Merck KGaA in the second quarter worth approximately $39,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Trading Down 3.9%
MKGAF opened at $158.15 on Friday. The stock’s fifty day moving average is $163.21 and its two-hundred day moving average is $148.95. The company has a market capitalization of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
